A little suprised at how well advanced the Conneqt band is. Personally did not put much emphasis to the success of this. A few statements below from the release.
"We are currently preparing the CONNEQT Band and its associated
mobile application for the final NIH RADx® prize round in November 2023"
"This means that our SphygmoCor technology can also be applied to finger-based and wearable devices such as pulse oximeters and mass market fitness trackers"
"21 participants, demonstrating clinical reliability of our ground-breaking device"
"The results have been extremely encouraging, consistently yielding
reliable results when compared to a tonometer-based approach, which is the “gold standard” for
arterial health assessments."
Great update and why i invested in this company.
But still one issue still not addressed.
Ann: CardieX - Go-to-Market (GTM) & Product Development Update, page-2
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.001(1.89%) |
Mkt cap ! $15.88M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.5¢ | 5.2¢ | $31.07K | 586.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 149188 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.3¢ | 5.4¢ | 5.3¢ | 56887 | ||
| Last updated 11.47am 03/05/2024 ? | |||||
| CDX (ASX) Chart |